![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1874-4702|9|3|226-230
ISSN: 1874-4672
Source: Current Molecular Pharmacology, Vol.9, Iss.3, 2016-08, pp. : 226-230
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Cisplatin + capecitabine active in head, neck squamous cell carcinoma
Inpharma, Vol. 1, Iss. 1475, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Cetuximab: A Review of its Use in Squamous Cell Carcinoma of the Head and Neck
Drugs, Vol. 70, Iss. 15, 2010-10 ,pp. :